美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
63323-725-10	63323-725	HUMAN PRESCRIPTION DRUG	Remifentanil Hydrochloride	Remifentanil Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180119	N/A	ANDA	ANDA206223	Fresenius Kabi USA, LLC	REMIFENTANIL HYDROCHLORIDE	1 mg/mL	10 VIAL, SINGLE-DOSE in 1 CARTON (63323-725-10) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-725-01)
63323-724-05	63323-724	HUMAN PRESCRIPTION DRUG	Remifentanil Hydrochloride	Remifentanil Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180119	N/A	ANDA	ANDA206223	Fresenius Kabi USA, LLC	REMIFENTANIL HYDROCHLORIDE	1 mg/mL	10 VIAL, SINGLE-DOSE in 1 CARTON (63323-724-05) / 5 mL in 1 VIAL, SINGLE-DOSE (63323-724-01)
63323-723-06	63323-723	HUMAN PRESCRIPTION DRUG	Remifentanil Hydrochloride	Remifentanil Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180119	N/A	ANDA	ANDA206223	Fresenius Kabi USA, LLC	REMIFENTANIL HYDROCHLORIDE	1 mg/mL	10 VIAL, SINGLE-DOSE in 1 CARTON (63323-723-06) / 3 mL in 1 VIAL, SINGLE-DOSE (63323-723-04)
63323-723-03	63323-723	HUMAN PRESCRIPTION DRUG	Remifentanil Hydrochloride	Remifentanil Hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20180119	N/A	ANDA	ANDA206223	Fresenius Kabi USA, LLC	REMIFENTANIL HYDROCHLORIDE	1 mg/mL	10 VIAL, SINGLE-DOSE in 1 CARTON (63323-723-03) / 3 mL in 1 VIAL, SINGLE-DOSE (63323-723-01)